The First Affiliated Hospital of Xiamen University clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 118 studies whose lead sponsor is The First Affiliated Hospital of Xiamen University. 79 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 21, 2026.
Keep track of what changes. Save the The First Affiliated Hospital of Xiamen University studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Where
- China
- 110
Studies
Recruiting first, then most recently updated. Showing 50 of 118. Browse all 118 →
- 68Ga-XHER2 PET/CT for HER2 AssessmentRecruitingNCT07885436Not applicable
- 68Ga-XMFH01 PET/Fluorescence Imaging in Prostate CancerRecruitingNCT07885423Not applicable
- Anxiety and Depression in Patients With Hematologic MalignanciesRecruitingNCT07883070
- DLL3-Targeted PET/CT in Neuroendocrine CarcinomaRecruitingNCT07458906Not applicable
- A Prospective Nurse Cohort Study in Xiamen, ChinaRecruitingNCT03799653
- GPC3-Targeted PET/CT in Hepatocellular CarcinomaRecruitingNCT07677774Not applicable
- Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal CarcinomaRecruitingNCT07137052
- Venetoclax, Chidamide, and Chiglitazar Sodium (VCC) in Patients With Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT07783100Phase 2
- Orelabrutinib Combined With Pola-R-CHP as First-Line Treatment for Patients With Intermediate- to High-Risk DLBCLRecruitingNCT07778212Not applicable
- Trophoblast Cell-Surface Antigen 2 (Trop-2) Targeted PET/CT in Recurrent and Metastatic Thyroid CancerRecruitingNCT07753499Not applicable
- Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCLRecruitingNCT07749365Phase 2
- DLL3-Targeted PET/CT in Small Cell Lung CancerRecruitingNCT07677787Not applicable
- the Effect of Transcutaneous Electrical Acupoint Stimulation on Postoperative Gastrointestinal Dysfunction After Urological Laparoscopic SurgeryRecruitingNCT07133620Not applicable
- Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles for the Treatment of Dry Eye DiseaseRecruitingNCT07623382Early Phase 1
- 68Ga-NK224 PET Imaging of PD-L1 Expression in CancersRecruitingNCT06754345
- Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye DiseaseRecruitingNCT07547930Phase 2
- Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT06992739Phase 2
- Using Healthy Gut Bacteria to Boost Immune Treatment for Advanced Bowel CancerNot yet recruitingNCT07486492Early Phase 1
- GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHLRecruitingNCT06875063Phase 1
- Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid TumorsNot yet recruitingNCT07438093Not applicable
- 68Ga-XACP3 PET/CT in Prostate CancerRecruitingNCT07242014Not applicable
- Pyrotinib Maleate Tablets in Combination With Dalpiciclib Isethionate Tablets and Standard Endocrine TherapyNot yet recruitingNCT07189884Phase 1/2
- The Effect of Semaglutide on Bone HealthNot yet recruitingNCT07165158Phase 4
- Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AMLRecruitingNCT05305859Phase 2
- PET/CT for Trop2 ADC Response Evaluation NSCLCRecruitingNCT07151898
- Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy RegimenNot yet recruitingNCT07137039Phase 2
- Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin αvβ3 Positive ExpressionRecruitingNCT06375564Phase 1
- 68Ga-FAPI-LM3 PET/CT Imaging in Patients With FAP/SSTR2 Positive Disease and Compared With 18F-FDGRecruitingNCT05873777Not applicable
- IMRT Combined With Lobaplatin-based CCRT in Nasopharyngeal CarcinomaEnrolling by invitationNCT06688175Phase 2
- Ultrasound Assessment of Fetal Growth ParametersEnrolling by invitationNCT07018362
- Iparomlimab/Tuvorlimab (QL1706) and Modified TPF Regimen for Induction Therapy in LANPCRecruitingNCT07085234Phase 2
- Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCLRecruitingNCT06651853Phase 2
- T-cell Developmental Status in Patients With Malignant Hematological TumorsRecruitingNCT07035938
- PET/CT for Trop2 ADC Response Evaluation CancersRecruitingNCT07046689
- 68Ga-MY6349 PET/CT in Solid TumorsRecruitingNCT07046702
- Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPCRecruitingNCT06811844Phase 2
- SBRT Combined With Nimotuzumab and Tislelizumab for Oligoprogressive Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of ImmunotherapyRecruitingNCT06676722Phase 2
- A Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung CancerNot yet recruitingNCT07031154Phase 2
- Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous CarcinomaNot yet recruitingNCT07019181Phase 2
- Trilaciclib in Combination With Docetaxel for Second-Line and Beyond Treatment of Locally Advanced or Metastatic NSCLCRecruitingNCT06929936Phase 2
- Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer PatientsRecruitingNCT06956144
- Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML PatientsRecruitingNCT06651866Phase 1
- Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AMLRecruitingNCT06737523Phase 1
- Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AMLRecruitingNCT06827899Phase 2
- Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FLRecruitingNCT06151080Phase 2
- Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular LymphomaRecruitingNCT06158386Phase 2
- All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple MyelomaRecruitingNCT06158412Phase 2
- Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell LymphomaRecruitingNCT06151106Phase 2
- 68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.RecruitingNCT06151119
- VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)RecruitingNCT05603884Phase 2